20 Selected HBV-related Abstracts Being Presented at AASLD 2023 - Adam Gehring, PhD

International Workshop on HBV Cure 2023

Bepirovirsen in Combination with Peg-IFN and Other Molecules - Stuart Kendrick, MD, PhD, MRCP

International Workshop on HBV Cure 2023

Second Generation CAMs Leading to HBsAg Decline - Matthew McClure, MD

International Workshop on HBV Cure 2023

Does siRNA Restore Host Control and Could it Lead to Sustained HBsAg Suppression? - Michael J. Sofia, Ph.D

International Workshop on HBV Cure 2023

Discrimination of Integrated vs. cccDNA Derived HBsAg - Chloe Thio, MD

International Workshop on HBV Cure 2023

Anti-HBs Monoclonal Antibodes in Nuc-naïve and Combo Therapies - Carey Hwang, MD, PhD

International Workshop on HBV Cure 2023

Value of Adding Recombinant Antigens to Viral Vector Vaccines - Ventzi Vassilev, PhD

International Workshop on HBV Cure 2023

Efficacy and Safety of Targeting PD-L1 with Monoclonal Antibodies - Jinzi J. Wu, Ph.D.

International Workshop on HBV Cure 2023

Immunological Profiles Induced by New Therapeutic Vaccines - Eleanor Barnes, PhD, FRCP, F. Med. Sci.

International Workshop on HBV Cure 2023

Balance of Response and Adverse Events in Immunotherapy for CHB - Jordan Feld, MD, MPH

International Workshop on HBV Cure 2023

Next Generation CAMs, New Life for Small Molecules? - Mark Sulkowski, MD

International Workshop on HBV Cure 2023

Latest Updates on Novel Biomarkers in HBV Cure - Man-Fung Yuen, MBBS, MD, PhD, DSc

International Workshop on HBV Cure 2023

Are We Only Able to Suppress HDV or is Cure in Reach? - Pietro Lampertico, MD, PhD

International Workshop on HBV Cure 2023

Expanding CHB Treatment Criteria with Nucs as Prelude of Novel Curative Therapies? - Harry Janssen, MD, PhD

International Workshop on HBV Cure 2023

Durability of Response After DAA Therapies - Fabien Zoulim, MD, PhD

International Workshop on HBV Cure 2023

Lifestyle Modifications - Fraja Chiwanga, MD, MMed (Int.Med), MSc

Conference on Liver Disease in Africa (COLDA) 2023

Pediatric Steatotic Liver Disease - Manal Hamdy El-Sayed, MD, PhD

Conference on Liver Disease in Africa (COLDA) 2023

A Global Action Agenda for Turning the Tide on Fatty Liver Disease - Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD

Conference on Liver Disease in Africa (COLDA) 2023

Management of Alcohol in Patients with Viral Hepatitis - Aleksander Krag, MD, PhD, MBA

Conference on Liver Disease in Africa (COLDA) 2023

Management of NASH in Patients with Viral Hepatitis - Maria Buti, MD, PhD

Conference on Liver Disease in Africa (COLDA) 2023

Role of Multidisciplinary Approach in Resource Limited Settings SOLDA Supported Session

Conference on Liver Disease in Africa (COLDA) 2023

HCC Tumor Board - Case Presentation - AASLD

Conference on Liver Disease in Africa (COLDA) 2023

Hepatocellular Carcinoma - Africa’s Experience - Ashraf Omar, MD, MSc

Conference on Liver Disease in Africa (COLDA) 2023

Platelet Count to Spleen Diameter Ratio as a Predictor of Oesophageal Varices in Patients with Liver Cirrhosis at Muhimbili National Hospital Dar es Salaam, Tanzania

Conference on Liver Disease in Africa (COLDA) 2023